From: Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature
Case | Reference | Age | Sex | Follow-up/survival (months) | Treatment | Tumor localization |
---|---|---|---|---|---|---|
1 | Yamaguchi et al. 2007 [9] | 14 | m | 8 (s) | -Etoposide | Disseminated BM infiltration, not specified |
-Cyclophosphamide | ||||||
-Pirarubicin | ||||||
-Cisplatin | ||||||
-Vincristine | ||||||
2 | Jani et al. (2009) [7] | 16 | m | 8 (s) | -VP16 | Disseminated BM infiltration, not specified |
-Ifosfamide | ||||||
-Vincristine | ||||||
-Adriamycin | ||||||
-Cyclophosphamide | ||||||
3 | Kern et al. (2015) [10] | 52 | f | 12 (s) | Not detailed | BM infiltration, not specified |
4 | Karagiannis et al. (2015) [8] | 61 | f | 7 (f) | -Topotecan | BM infiltration, not specified |
-Cyclophosphamide | ||||||
-Vinorelbine (Monotherapy-later) | ||||||
5 | Case 1 (current report) | 17 | m | 7 (s) | -Ifosfamid | Diffuse BM infiltration |
-Carboplatin | ||||||
-Etoposid | ||||||
-Vincristin | ||||||
6 | Case 2 (current report) | 9 | m | 30 (s) | -Ifosfamid | Tibia, femur, pelvic bones, vertebrae |
-Etoposid | ||||||
-Carboplatin | ||||||
-Topotecan |